Group 1: Major Announcements - Huapei Power plans to acquire 100% equity of Meichuang Zhiguan (Wuxi) Technology Co., Ltd. through convertible bonds and cash, with trading suspension starting from February 13 [2][3] - Zhongnan Culture is planning a major asset restructuring by acquiring controlling interest in Jiangyin Sulong Thermal Power Co., Ltd. through share issuance and cash payment, with trading suspension starting from February 13 [3] - Xiechuang Data intends to purchase servers from multiple suppliers, with a total contract amount expected to not exceed 11 billion [4] Group 2: Investment Projects - Hudian Co. plans to invest 3.3 billion in a new high-end printed circuit board production project, aiming to meet the growing demand for high-end PCBs in high-performance computing and next-generation networking [5] - Penghui Energy plans to invest a total of 3.3 billion in battery and cell production projects [11] - Jingrui Electric Materials intends to invest 600 million in a comprehensive base for key materials in the integrated circuit manufacturing industry chain in the western region [11] Group 3: Performance Reports - Jinyuanzi reported a total revenue of 253.4 million for 2025, a year-on-year increase of 19.46%, with a net profit of 37.3 million, up 22.20% [7] - Youyan Powder Materials reported a total revenue of 3.9 billion for 2025, a year-on-year increase of 20.85%, with a net profit of 7.1 million, up 19.41% [7] Group 4: Fundraising and Restructuring - Wenzhou Hongfeng plans to raise no more than 450 million through a private placement for lithium battery copper foil and semiconductor etching projects [9] - Yingkerui plans to raise no more than 379 million for various projects including smart high-frequency power supply systems [9] - China Shenhua received approval for issuing shares to acquire assets and raise matching funds [9] Group 5: Important Contracts and Orders - ST Songfa signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion and 1.8 billion [11] - Zhiguang Electric's subsidiary received a 210 million order for energy storage equipment [16] - Terui De is expected to win a bid for a renewable energy project worth approximately 137 million [16]

Group 1 - Jia Mei Packaging announced that the capital operation plan related to Magic Atom will be completely independent of the listed company, with no injection plan [2] - Shuangliang Energy indirectly participates in commercial aerospace projects but does not have direct cooperation with SpaceX [2] - Zhangyue Technology expects that the revenue from its AI short drama business in 2025 will not exceed 1% of its total annual revenue [2] Group 2 - Xianglu Tungsten stated that significant economic fluctuations in the countries of its main customers could greatly impact the demand for tungsten products and the recovery of accounts receivable [3] - United Optoelectronics signed a business cooperation framework contract with Lingzhi Cloud Creation to provide assembly and processing services for robot products [4] - Hanbo High-tech's subsidiary plans to acquire assets to layout the wet electronic chemicals industry [4] Group 3 - International Composite Materials confirmed that electronic-grade glass fiber is a key raw material for PCBs and that its operations are normal [5] - Jingrui Electric Materials plans to invest 600 million yuan to build a comprehensive base for key materials in the integrated circuit manufacturing industry in the western region [6] - Wenzhou Hongfeng intends to raise no more than 450 million yuan for the expansion of lithium battery copper foil and electronic copper foil projects [7] Group 4 - Zhi Chuang Data plans to procure servers from multiple suppliers, with a total expected amount not exceeding 11 billion yuan [8] - Zhangyuan Tungsten reported that its current operating conditions and external environment are normal, with no undisclosed significant matters [17] - Yida Co. plans to adjust the technical reform project for the production of 220,000 tons of epoxy propylene derivatives [19] Group 5 - Huazhong Bank reported a net profit of 27.2 billion yuan for 2025, a decrease of 1.72% year-on-year [27][28] - Jin Dike reported a net loss of 173 million yuan for 2025, despite a revenue increase of 40.13% [29] - Luan An Huan Neng reported a 16.8% year-on-year increase in coal sales in January 2026 [30]

Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

每经AI快讯，怡达股份2月12日晚间发布公告称，公司第五届第九次董事会会议于2026年2月12日在公 司会议室召开。会议审议了《关于对外投资项目变更的议案》等文件。 每经头条（nbdtoutiao）——打造百万元级尊界的江淮，迎来葛卫东、方文艳联手投资：两人各掏10亿 元，公司股价应声大涨！复盘历史：牛散参与定增有赚也有亏 （记者 曾健辉） ...

江苏怡达化学股份有限公司 第五届董事会第九次会议决议公告 证券代码：300721 证券简称: 怡达股份 公告编号：2026-004 （一）《关于对外投资项目变更的议案》 为迎合未来市场发展需求以及原项目建设地受长江"一公里"岸线（洋思港 闸河道管理范围边界线一公里）政策影响，公司控股子公司泰兴怡达化学有限公 司拟对"年产 22 万吨环氧丙（乙）烷衍生产品技改项目"整体方案进行如下调整： 1、减少原项目三羟乙基异氰尿酸酯（赛克）产品 2 万吨，同时变更后的项目 名称为："年产 20 万吨环氧丙（乙）烷衍生产品项目"，项目总投资额由人民币 8.45 亿元减少至人民币 6.42 亿元； 2、投资项目地址变更为泰兴经济开发区通江路中港路 1 号（万淇生物科技（泰 州）有限公司厂区内）。 本次对外投资项目变更有助于加快项目建设进程，进一步优化完善公司"三 1 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏怡达化学股份有限公司（以下简称"公司"）于 2026 年 2 月 12 日上 午 9:30 在公司会议室召开第五届董事会第九次会议，会议通 ...

证券代码：300721 证券简称: 怡达股份 公告编号：2026-005 江苏怡达化学股份有限公司 1 关于对外投资项目变更的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、前述投资事项概述 江苏怡达化学股份有限公司（以下简称"怡达股份"或"公司"）于 2022 年 12 月 14 日召开了第四届董事会第十一次会议，审议通过了《关于投资建设泰 兴怡达二期项目的议案》，公司投资建设"年产 22 万吨环氧丙（乙）烷衍生品技 改项目"，项目拟建地点：泰兴怡达化学有限公司厂区预留用地内，计划总投资 84,548 万 元 。 具 体 内 容 详 见 公 司 于 2022 年 12 月 15 日 于 巨 潮 资 讯 网 （https://www.cninfo.com.cn）刊登的《关于投资建设泰兴怡达二期项目的公告》 （公告编号：2022-074）。 二、本次对外投资项目变更情况 为迎合未来市场发展需求以及原项目建设地受长江"一公里"岸线（洋思港 闸河道管理范围边界线一公里）政策影响，公司控股子公司泰兴怡达化学有限公 司拟对"年产 22 万吨环氧丙（乙）烷衍生产 ...

Group 1 - The core viewpoint of the news is that Yida Co., Ltd. (300721) clarified on its interactive platform that the company does not have TMP products, which helps to eliminate potential market misunderstandings [1] - The epoxy propylene sector experienced a significant price increase in January due to adjustments in export tax policies, with Yida Co., Ltd. seeing a stock price increase of 37.78% in January [1] - However, in early February, industry prices began to correct, leading to market concerns regarding changes in supply and demand dynamics [1] Group 2 - In the recent stock performance, Yida Co., Ltd. showed notable volatility over the past week (February 5 to February 11, 2026), with a slight decline of 0.12% and a fluctuation range of 12.45% [2] - On February 9, the stock price rose by 3.95% to 17.39 yuan, with a trading volume of 436 million yuan; however, it fell by 4.03% to 16.69 yuan on February 10 and further decreased by 1.98% to 16.36 yuan on February 11, indicating a net outflow of 4.5485 million yuan in principal funds [2] - The turnover rate remained high, indicating active short-term trading [2]

Group 1 - The company, Yida Co., Ltd. (300721.SZ), stated on the investor interaction platform that it does not have TMP products [1]

Core Viewpoint - The epoxy propylene sector has experienced a significant price surge since January, with various companies seeing substantial stock price increases, driven by supply-demand dynamics and market speculation [2][3][4]. Price Increase - In January, stock prices of companies related to epoxy propylene saw remarkable increases, with Meibang Technology rising by 67.45% and Hongbaoli by 68.92% [3]. - The benchmark price of epoxy propylene reached 8200.00 yuan/ton by January 30, marking a 6.03% increase from the beginning of the month, with some periods seeing nearly a 10% rise [4]. Supply and Demand Dynamics - The price increase is attributed to changes in the supply-demand landscape, with reduced operating loads in northern regions and a positive outlook in the downstream market leading to increased purchasing activity [4][5]. - The cancellation of export tax rebates for certain products is expected to drive a surge in orders before the April deadline, further boosting demand for epoxy propylene [5]. Market Trends - Despite the price surge, there are signs of a cooling market as purchasing sentiment declines due to high prices, leading to a potential downward adjustment in prices [6]. - The epoxy propylene industry is currently experiencing an oversupply situation, with low operating rates and expected new capacity additions by 2026 [6][7]. Demand Growth - Although there is oversupply, demand for epoxy propylene is showing slight growth, particularly in the appliance and export sectors, which is helping to sustain overall demand [7]. - The market is expected to experience fluctuations in February, with potential price rebounds later in the month as downstream factories resume operations [8].

Group 1 - The core point of the article is that Yida Co., Ltd. announced the absorption merger of its wholly-owned subsidiary, Wanqu Biotechnology (Taizhou) Co., Ltd., by its controlling subsidiary, Taixing Yida Chemical Co., Ltd. [2] - The independent legal status of Wanqu is expected to be canceled after January 31, 2026, with all assets, liabilities, personnel, and business being inherited by Taixing Yida [2] - The registered capital of Taixing Yida will remain unchanged at 72 million yuan after the merger, which aims to optimize the management structure and reduce operational costs, having no substantial impact on the company's consolidated financial statements and profitability [2]